BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 8917339)

  • 1. Effects of liposomal antisense oligonucleotides on mRNA and protein levels of the HPV 16 E7 oncogene.
    Lappalainen K; Pirilä L; Jääskeläinen I; Syrjänen K; Syrjänen S
    Anticancer Res; 1996; 16(5A):2485-92. PubMed ID: 8917339
    [TBL] [Abstract][Full Text] [Related]  

  • 2. In vitro and in vivo inhibition of human papillomavirus type 16 E6 and E7 genes.
    Tan TM; Ting RC
    Cancer Res; 1995 Oct; 55(20):4599-605. PubMed ID: 7553636
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cationic liposomes mediated delivery of antisense oligonucleotides targeted to HPV 16 E7 mRNA in CaSki cells.
    Lappalainen K; Urtti A; Jääskeläinen I; Syrjänen K; Syrjänen S
    Antiviral Res; 1994 Feb; 23(2):119-30. PubMed ID: 8147581
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vitro antigene therapy targeting HPV-16 E6 and E7 in cervical carcinoma.
    Madrigal M; Janicek MF; Sevin BU; Perras J; Estape R; Peñalver M; Averette HE
    Gynecol Oncol; 1997 Jan; 64(1):18-25. PubMed ID: 8995542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mechanism of translation of the bicistronic mRNA encoding human papillomavirus type 16 E6-E7 genes.
    Tan TM; Gloss B; Bernard HU; Ting RC
    J Gen Virol; 1994 Oct; 75 ( Pt 10)():2663-70. PubMed ID: 7931152
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of human papillomavirus type 18-specific antisense oligonucleotides on the transformed phenotype of human carcinoma cell lines.
    Steele C; Cowsert LM; Shillitoe EJ
    Cancer Res; 1993 May; 53(10 Suppl):2330-7. PubMed ID: 7683572
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biologic activity of oligonucleotides with polarity and anomeric center reversal.
    Tan TM; Kalisch BW; van de Sande JH; Ting RC; Tan YH
    Antisense Nucleic Acid Drug Dev; 1998 Apr; 8(2):95-101. PubMed ID: 9593047
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retrovirus-mediated delivery of HPV16 E7 antisense RNA inhibited tumorigenicity of CaSki cells.
    Choo CK; Ling MT; Suen CK; Chan KW; Kwong YL
    Gynecol Oncol; 2000 Sep; 78(3 Pt 1):293-301. PubMed ID: 10985883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of combined antisense oligodeoxynucleotides directed against the human papillomavirus type 16 on cervical carcinoma cells.
    Márquez-Gutiérrez MA; Benítez-Hess ML; DiPaolo JA; Alvarez-Salas LM
    Arch Med Res; 2007 Oct; 38(7):730-8. PubMed ID: 17845891
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Silencing of HPV 18 oncoproteins With RNA interference causes growth inhibition of cervical cancer cells.
    Lea JS; Sunaga N; Sato M; Kalahasti G; Miller DS; Minna JD; Muller CY
    Reprod Sci; 2007 Jan; 14(1):20-8. PubMed ID: 17636212
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antisense RNA directed to the human papillomavirus type 16 E7 mRNA from herpes simplex virus type 1 derived vectors is expressed in CaSki cells and downregulates E7 mRNA.
    Kari I; Syrjänen S; Johansson B; Peri P; He B; Roizman B; Hukkanen V
    Virol J; 2007 Jun; 4():47. PubMed ID: 17547759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PreTect HPV-Proofer: real-time detection and typing of E6/E7 mRNA from carcinogenic human papillomaviruses.
    Molden T; Kraus I; Skomedal H; Nordstrøm T; Karlsen F
    J Virol Methods; 2007 Jun; 142(1-2):204-12. PubMed ID: 17379322
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of radiation-induced apoptosis by dexamethasone in cervical carcinoma cell lines depends upon increased HPV E6/E7.
    Kamradt MC; Mohideen N; Krueger E; Walter S; Vaughan AT
    Br J Cancer; 2000 May; 82(10):1709-16. PubMed ID: 10817508
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cyclooxygenase-2 transcription is regulated by human papillomavirus 16 E6 and E7 oncoproteins: evidence of a corepressor/coactivator exchange.
    Subbaramaiah K; Dannenberg AJ
    Cancer Res; 2007 Apr; 67(8):3976-85. PubMed ID: 17440114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adenoviral p53 effects and cell-specific E7 protein-protein interactions of human cervical cancer cells.
    Choi JW; Ahn WS; Bae SM; Lee DB; Kim YW
    Biosens Bioelectron; 2005 May; 20(11):2236-43. PubMed ID: 15797321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antisense targeting human papillomavirus type 16 E6 and E7 genes contributes to apoptosis and senescence in SiHa cervical carcinoma cells.
    Sima N; Wang S; Wang W; Kong D; Xu Q; Tian X; Luo A; Zhou J; Xu G; Meng L; Lu Y; Ma D
    Gynecol Oncol; 2007 Aug; 106(2):299-304. PubMed ID: 17586029
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cleavage of HPV-16 E6/E7 mRNA mediated by modified 10-23 deoxyribozymes.
    Reyes-Gutiérrez P; Alvarez-Salas LM
    Oligonucleotides; 2009 Sep; 19(3):233-42. PubMed ID: 19732021
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracellular distribution of oligonucleotides delivered by cationic liposomes: light and electron microscopic study.
    Lappalainen K; Miettinen R; Kellokoski J; Jääskeläinen I; Syrjänen S
    J Histochem Cytochem; 1997 Feb; 45(2):265-74. PubMed ID: 9016315
    [TBL] [Abstract][Full Text] [Related]  

  • 19. High human papillomavirus oncogene mRNA expression and not viral DNA load is associated with poor prognosis in cervical cancer patients.
    de Boer MA; Jordanova ES; Kenter GG; Peters AA; Corver WE; Trimbos JB; Fleuren GJ
    Clin Cancer Res; 2007 Jan; 13(1):132-8. PubMed ID: 17200347
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Antisense oligonucleotides resistance to coxsackievirus B3 infection in HeLa cells].
    Sun H; Liu Z; Zhang T
    Zhonghua Liu Xing Bing Xue Za Zhi; 2000 Aug; 21(4):295-7. PubMed ID: 11860805
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.